THERON PHARMACEUTICALS INC has a total of 18 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2011. It filed its patents most often in United States, China and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are SALIX PHARMACEUTICALS LTD, SCHERING PLOUGH KABUSHIKI KAIS and MERLION PHARMACEUTICALS PTE LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | China | 3 | |
#3 | Canada | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Republic of Korea | 2 | |
#6 | Mexico | 2 | |
#7 | WIPO (World Intellectual Property Organization) | 2 | |
#8 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Zhang Xiaoming | 17 |
#2 | Venkatraman Meenakshi S | 17 |
#3 | Rescourio Gwenaella | 11 |
#4 | Pfister Jurg R | 9 |
#5 | Haywood Phillip | 6 |
#6 | Pfister Jürg R | 2 |
#7 | Meenakshi S Venkatraman | 1 |
#8 | Phillip Haywood | 1 |
#9 | Xiaoming Zhang | 1 |
Publication | Filing date | Title |
---|---|---|
KR20180101438A | A dry powder inhaler composition of 7-azoniabicyclo [2.2.1] heptane derivative | |
KR20130004274A | 7-azoniabicyclo [2.2.1] heptane derivatives, methods of production, and pharmaceutical uses thereof |